Inflammation
Inflammation represents the coordinated immune response to infection, trauma and injury.
When appropriately controlled, inflammation ensures competent host defence and prevents excessive damage of the affected tissue or organ structure.
In chronic inflammatory diseases, this process is disrupted and instead of offering protection, drives disease progression.
Theme lead
Area of interest
Cytokine immunology in chronic disease progression.
Principal members of staff
| Name | Area of interest |
|---|---|
| Professor Ernest Choy | Clinical rheumatology and biologic drug therapies |
| Professor Andrew Finlay | Infection |
| Professor Paul Martin | Cancer and wound healing |
| Dr John Ingram | Clinical dermatology |
| Professor Valerie O'Donnell | Lipidomics |
| Professor Peter Collins | Clinical haematology and clotting |
| Professor Paul Morgan | Complement biology, neuroimmunology |
| Professor Kathy Triantafilou | |
| Dr Martha Triantafilou | Innate sensing mechanisms |
| Dr Timothy Hughes | Complement biology, cardiovascular disease |
| Professor Donald Fraser | Clinical nephrology and fibrosis |
| Dr Timothy Bowen | MicroRNA |
| Dr Anne-Catherine Raby | Innate sensing mechanisms |
| Professor Aled Phillips | Clinical nephrology and renal scarring |
| Dr Soma Meran | Clinical nephrology and fibrosis |
| Professor Philip Taylor | Monocytic cell biology |
| Professor Anwen Williams | Experimental rheumatology |
| Dr Gareth Jones | Cytokine immunology in chronic disease progression |
| Dr Selinda Orr | Innate sensing mechanisms |
Research Groups
Our research creates benefits across health, society and the economy.